Cronos Group Inc. Overview
Pro stress-test →Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. The company reported record net revenue of $44.5M in Q4 2025 and $146.6M for FY 2025, up 47% and 25% year-over-year respectively.
Strategic Profile
Pro stress-test →Cronos' diverse international brand portfolio includes Spinach®, PEACE NATURALS®, and Lord Jones®. The company delivered record quarterly net revenue in Canada up 42% year-over-year, with Israel net revenue growing 52% year-over-year marking the eighth consecutive quarter of record net revenue in that market. With GrowCo's expansion now complete, Cronos expects constraints to ease in 2026 as the expanded cultivation space becomes more fully optimized.
Competitive Landscape
Pro stress-test →Cronos' diverse international brand portfolio includes Spinach, a mainstream adult-use cannabis brand with products in dried flower, pre-rolls, vaporizers, edibles and tinctures, alongside PEACE NATURALS and Lord Jones. Primary competitors include Aurora Cannabis, Tilray Brands, Curaleaf Holdings (US-focused), Green Thumb Industries, and other large-scale cannabis multistate operators. Cronos differentiates through IP development, premium positioning, and focused international expansion.
Industry Context
Cronos Group Inc. operates in Cannabis/Cannabinoids - Medical & Adult-Use.
Key facts
Headquarters: Toronto, Canada · Revenue: $146.6M (FY 2025) · Market cap: $935M